Vitruvian invests $637m in health tech firm DeepIntent

Vitruvian will acquire a majority stake in DeepIntent following this transaction.

11 September 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.